ascorbic acid + biotin + calcium + 22 other active ingredients: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
ascorbic acid + biotin + calcium + 22 other active ingredients: clinical details
Prescribing considerations
- Confirm a credible nutritional indication and assess dietary protein and energy adequacy.
- Review prescribed, over-the-counter and nutritional products for duplicate vitamins and minerals.
- Patients with thyroid disorders should obtain medical advice before use.
- Discuss the potential beta-carotene risk with current smokers and people previously exposed to asbestos.
Contraindications and cautions
- Hypercalcaemia.
- Haemochromatosis or another iron-storage disorder.
- Hypersensitivity to an active ingredient or excipient.
- Peanut or soya allergy because the formulation contains soya bean oil.
Monitoring
- No routine monitoring schedule is specified; tailor assessment to the indication, malabsorption, comorbidity and interacting medicines.
- Review iron and calcium status where accumulation is possible or suspected.
- Consider thyroid status and medicine absorption when relevant.
Clinical pharmacology
A combined replacement product supplying water- and fat-soluble vitamins, macrominerals and trace elements that support enzymatic reactions, antioxidant defence, blood-cell production, collagen formation, calcium–phosphate handling, thyroid function and cellular metabolism.
Formulation and product differences
- The selected product is a brown-and-maroon soft gelatin capsule intended to be swallowed whole.
- Vitamin A activity is supplied as beta-carotene and vitamin D as ergocalciferol.
- The capsule contains soya bean oil, soya lecithin and gelatin.
- Amaranth and Ponceau 4R colouring agents may cause allergic reactions.
ascorbic acid + biotin + calcium + 22 other active ingredients interactions
Folic acid and mineral ingredients can alter the absorption or blood concentrations of some medicines. Ask a pharmacist whether administration needs separating.
Phenytoin
Folic acid can reduce phenytoin plasma concentrations, potentially affecting seizure control.
Tetracycline antibiotics
Iron and zinc can reduce tetracycline absorption.
Levothyroxine
Iron, calcium and multivitamin products can reduce levothyroxine absorption.
Quinolone antibiotics, bisphosphonates and HIV integrase inhibitors
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.